Gen-Probe announces that the company has prevailed in its arbitration with Digene (now Qiagen) concerning the its supply and purchase agreement with Roche for human papillomavirus (HPV) products.
Read More
The rapidly expanding portfolio of tumor markers
Read MoreResults from an eight-year trial published in NEJM demonstrates that in low-resource settings a single round of HPV testing significantly reduces the numbers of advanced cervical cancers and deaths, compared with Pap (cytology) testing or visual inspection with acetic acid.
Read MoreA blood test that can help predict the seriousness of a head injury and detect the status of the blood-brain barrier is a step closer to reality, according to two recently published studies.
Read MoreARUP Laboratories and the American Association for Clinical Chemistry (AACC) announced today that a consensus guideline for a key laboratory method called qPCR (or quantitative polymerase chain reaction) was published by a group of international scientists representing the medical and research fields.
Read More